A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib Versus Placebo in Men With Prostate Cancer With Rising PSA Following Prostatectomy or Radiation Therapy
Phase of Trial: Phase II/III
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Celecoxib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 08 Dec 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 Mar 2007 The expected completion date for this trial is now 1 Jan 2005.